Artículo
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
Lorenzo Martín, L. Francisco; Menacho Márquez, Mauricio Ariel
; Fernández Parejo, Natalia; Rodríguez Fdez, Sonia; Pascual, Gloria; Abad, Antonio; Crespo, PIero; Dosil, Mercedes; Benitah, Salvador A.; Bustelo, Xosé R.
Fecha de publicación:
05/2022
Editorial:
Nature Publishing Group
Revista:
Oncogene
ISSN:
0950-9232
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
It is known that Rho GTPases control different aspects of the biology of skin stem cells (SSCs). However, little information is available on the role of their upstream regulators under normal and tumorigenic conditions in this process. To address this issue, we have used here mouse models in which the activity of guanosine nucleotide exchange factors of the Vav subfamily has been manipulated using both gain- and loss-of-function strategies. These experiments indicate that Vav2 and Vav3 regulate the number, functional status, and responsiveness of hair follicle bulge stem cells. This is linked to gene expression programs related to the reinforcement of the identity and the quiescent state of normal SSCs. By contrast, in the case of cancer stem cells, they promote transcriptomal programs associated with the identity, activation state, and cytoskeletal remodeling. These results underscore the role of these Rho exchange factors in the regulation of normal and tumor epidermal stem cells.
Palabras clave:
stem cells
,
skin
,
Vav
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IDICER)
Articulos de INSTITUTO DE INMUNOLOGIA CLINICA Y EXPERIMENTAL DE ROSARIO
Articulos de INSTITUTO DE INMUNOLOGIA CLINICA Y EXPERIMENTAL DE ROSARIO
Citación
Lorenzo Martín, L. Francisco; Menacho Márquez, Mauricio Ariel; Fernández Parejo, Natalia; Rodríguez Fdez, Sonia; Pascual, Gloria; et al.; The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function; Nature Publishing Group; Oncogene; 41; 24; 5-2022; 3341-3354
Compartir
Altmétricas